{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-26-013383","form_type":"8-K","ticker":"PLSE","cik":"0001625101","company_name":"PULSE BIOSCIENCES, INC.","filed_at":"2026-04-27T23:59:59+00:00","discovered_at":"2026-05-14T18:02:32.608122+00:00","generated_at":"2026-05-15T03:51:59.846886+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"Pulse Biosciences reports 100% 6-month and 96% 12-month ablation success in nPulse study","bullets":["Sustained 100% procedural success at 6 months (95/95 evaluable patients by holter).","Sustained 96% procedural success at 12 months (51/53 evaluable patients).","90% Kaplan-Meier freedom from AF/AFL/AT at one year; low SAE rate of 1.7% (3/177).","Efficient procedure: left atrial dwell 18.6 min, total procedure 60.2 min, fluoroscopy 9.4 min.","Data presented at Heart Rhythm 2026 by Dr. Vivek Reddy; 177 patients treated across 7 European sites."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-26-013383","json":"https://secwatch.observer/filing/0001437749-26-013383.json","markdown":"https://secwatch.observer/filing/0001437749-26-013383.md","text":"https://secwatch.observer/filing/0001437749-26-013383.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926013383/0001437749-26-013383-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1625101/000143774926013383/plse20260424_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T03:51:59.846886+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}